Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

Viral Meningitis

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccinations

Vaccinations

Diphtheria

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neurological manifestations in children with SARS-CoV-2 infection: a French multicentric cohort.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2025

Same author

Lyme neuroborreliosis in children: Report of nine cases and a review of the literature.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019

Same author

[Contribution of teledermatology in a hospital pediatrics department].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017

Same author

[Evaluating a child after a febrile seizure: Insights on three important issues].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017

Same author

[Teledermatology between two French hospitals: Two years of experience].

Annales de dermatologie et de venereologie·2017

Same author

[Congenital nodules of the foot soles].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017

Search research articles

Related Experiment Video

Updated: May 19, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

[Meningococcal serogroup B vaccines].

M-A Dommergues¹

¹Centre Hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France. madommergues@orange.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie

|August 14, 2012

Summary

Developing a broadly protective vaccine against diverse Neisseria meningitidis serogroup B strains remains difficult. Recombinant factor H binding protein vaccines show promise for covering most group B strains.

Area of Science:

Microbiology
Immunology
Vaccinology

Context:

Neisseria meningitidis serogroup B presents significant antigenic diversity globally.
Existing vaccines, like outer-membrane vesicles, are often strain-specific and geographically limited.
Developing a universal vaccine for serogroup B is a critical public health goal.

Purpose:

To review the challenges and advancements in developing vaccines against Neisseria meningitidis serogroup B.
To evaluate the potential of recombinant protein vaccines, specifically targeting factor H binding protein, for broad group B coverage.

Summary:

The antigenic variability of Neisseria meningitidis serogroup B strains poses a major obstacle to broad vaccine efficacy.
Outer-membrane vesicle vaccines, while safe and effective, are typically strain-specific.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Experiment Videos

Last Updated: May 19, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Recombinant protein vaccines, including those based on factor H binding protein, offer a promising strategy for achieving wider protection against diverse group B strains.

Impact:

Advances in recombinant protein vaccine development could lead to more effective and broadly applicable vaccines against meningococcal disease.
Improved vaccine strategies are crucial for controlling outbreaks caused by Neisseria meningitidis serogroup B.
This research informs future vaccine design and public health strategies for meningococcal disease prevention.